Purchase Print Copy

 FormatList Price
Add to Cart Paperback8 pages Free

The Health Plan Employer Data and Information Set (HEDIS) is a set of performance measures used to assess the quality of care delivered in managed care plans. Chlamydia screening among young women is one new measure recently adopted by the National Committee for Quality Assurance for inclusion in HEDIS. An essential criterion for new measures is that the clinical intervention is beneficial to health and cost-effective. The study seeks to assess the health benefits and cost-effectiveness of chlamydia screening among young women. Articles addressing the epidemiology of chlamydia infection, its health consequences, and the benefits, problems and cost-effectiveness of chlamydia screening were reviewed. The authors conclude that the National Committee for Quality Assurance's recent adoption of the measure for chlamydia screening among young women into the formal HEDIS measurement set is justifiable from a health benefit standpoint and from a cost-effectiveness standpoint.

Originally published in: Sexually Transmitted Diseases, v. 26, no. 6, 1999, pp. 309-316.

This report is part of the RAND Corporation reprint series. The Reprint was a product of the RAND Corporation from 1992 to 2011 that represented previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see External Publications.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.